Marek Kubin

13.8k citations

53 papers · 11.8k indexed · 6 hit papers · h-index 39

Impact in

Immunology top 0.1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
Cancer Research top 1%
- NF-κB Signaling Pathways

Papers in

Immunology 42
- Immune Cell Function and Interaction 24
- T-cell and B-cell Immunology 16
- Immune Response and Inflammation 11
- Immunotherapy and Immune Responses 8
- interferon and immune responses 4
Dermatology 9

Co-authors: Giorgio Trinchieri Annalisa D’Andrea David Cosman Thomas S. Griffith Wilson Chin Nicholas M. Valiante David H. Lynch Miguel Aste-Amézaga
Journals: The Journal of Immunology (13 papers)The Journal of Experimental Medicine (5 papers)Journal of Investigative Dermatology (4 papers)Blood (4 papers)Journal of Biological Chemistry (3 papers)
Partner nations: United States Canada Italy

In The Last Decade

Marek Kubin

52 papers receiving 11.6k citations

Hit Papers

6 papers align trajectories log scale

ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor 2001 · 982 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 Immunity
1999 Nature Medicine
1998 The Journal of Immunology
1997 Immunity
1993 The Journal of Experimental Medicine
1992 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Marek Kubin

Since Specialization

Citations

This map shows the geographic impact of Marek Kubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Kubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Kubin more than expected).

Fields of papers citing papers by Marek Kubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Kubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Kubin. The network helps show where Marek Kubin may publish in the future.

Co-authors

The 25 scholars most cited alongside Marek Kubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marek Kubin Line = papers co-authored together Marek Kubin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway International Immunology ·Béatrice Le Maux Chansac, Dorothée Missé, Catherine Richon, Isabelle Vergnon, Marek Kubin, Jean‐Charles Soria, Alessandro Moretta, Salem Chouaı̈b, Fathia Mami‐Chouaib	2008	24
2	NK Cells Infiltrating a MHC Class I-Deficient Lung Adenocarcinoma Display Impaired Cytotoxic Activity toward Autologous Tumor Cells Associated with Altered NK Cell-Triggering Receptors The Journal of Immunology ·Béatrice Le Maux Chansac, Alessandro Moretta, Isabelle Vergnon, Paule Opolon, Yann Lécluse, Dominique Grunenwald, Marek Kubin, Jean‐Charles Soria, Salem Chouaı̈b, Fathia Mami‐Chouaib	2005	65
3	UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells The Journal of Immunology ·Claire L. Sutherland, N. Jan Chalupny, Kenneth Schooley, Tim VandenBos, Marek Kubin, David Cosman	2002	211
4	Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo Nature Medicine ·Henning Walczak, Robert E. Miller, K. Ariail, Brian Gliniak, Thomas S. Griffith, Marek Kubin, Emarisa Emarisa, Jon Jones, Anjali Sharathkumar, Tiep Le, Craig A. Smith, Evevanne Hottel, Raymond G. Goodwin, Charles T. Rauch, JoAnn C. L. Schuh, David H. Lynch Hit paper breakdown →	1999	2158
5	Interleukin-1 Protects Transformed Keratinocytes from Tumor Necrosis Factor-related Apoptosis-inducing Ligand- and CD95-induced Apoptosis but Not from Ultraviolet Radiation-induced Apoptosis Journal of Biological Chemistry ·Abiodun Aderibigbe, Dagmar Kulms, Thomas A. Luger, Marek Kubin, Thomas Schwarz	1999	59
6	Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL The Journal of Experimental Medicine ·Thomas S. Griffith, Steven R. Wiley, Marek Kubin, Lisa M. Sedger, Charles R. Maliszewski, Neil A. Fanger	1999	408
7	Retinoids Synergize with Interleukin-2 to Augment IFN-gamma and Interleukin-12 Production by Human Peripheral Blood Mononuclear Cells Journal of Interferon & Cytokine Research ·Floyd E. Fox, Marek Kubin, Maureen Cassin, K Emami, Giorgio Trinchieri, Kevin D. Cooper, Alain H. Rook	1999	42
8	Interleukin-1 Protects Transformed Keratinocytes from Tumor Necrosis Factor-related Apoptosis-inducing Ligand Journal of Biological Chemistry ·Abiodun Aderibigbe, Dagmar Kulms, Birgit Pöppelmann, Thomas A. Luger, Marek Kubin, Thomas Schwarz	1998	92
9	Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells The Journal of Immunology ·Thomas S. Griffith, Wilson Chin, Ina Ciobanu, David H. Lynch, Marek Kubin Hit paper breakdown →	1998	588
10	Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus Arthritis & Rheumatism ·David A. Horwitz, J. Dixon Gray, Adithya Krishna S.B, Marek Kubin, Manthrasalam Rengaraju, Kazuo Ohtsuka, Giorgio Trinchieri	1998	189
11	Calcitonin Gene-Related Peptide Inhibits Proliferation and Antigen Presentation by Human Peripheral Blood Mononuclear Cells: Effects on B7, Interleukin 10, and Interleukin12 Journal of Investigative Dermatology ·Floyd E. Fox, Marek Kubin, Maureen Cassin, Zhutian Niu, Junichi Hosoi, Hideshi Torii, Richard D. Granstein, Giorgio Trinchieri, Alain H. Rook	1997	95
12	A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules Immunity ·David Cosman, Neil A. Fanger, Luís Borges, Marek Kubin, Wilson Chin, Saidatulakm Jamalludin Sulaiman, А. РУФОВА А Hit paper breakdown →	1997	570
13	A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. The Journal of Experimental Medicine ·Yasir A. W. Skeiky, Jeffrey A. Guderian, Darin R. Benson, Daniel Wondifraw, Edgar M. Carvalho, Marek Kubin, Roberto Badaró, Giorgio Trinchieri, Steven G. Reed	1995	146
14	IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. The Journal of Immunology ·Alain H. Rook, Marek Kubin, Maureen Cassin, C Bercovich, Benjamin R. Vowels, Jonathan Wolfe, S F Wolf, Anurag Singh, Giorgio Trinchieri, Stuart R. Lessin	1995	108
15	Production of interleukin-12 Research in Immunology ·Xiaojing Ma, Annalisa D’Andrea, Marek Kubin, Miguel Aste-Amézaga, Alexandrina Sartori, Šárka Buřilová, Louise C. Showe, Maria Wysocka, Giorgio Trinchieri	1995	35
16	Detection of the production of interleukin (IL) 12 by human keratinocytes Journal of Investigative Dermatology ·Yoshinori Aragane, Helge Riemann, Ranjit Bhardwaj, Agatha Schwarz, Thomas A. Luger, Marek Kubin, Giorgio Trinchieri, Thomas Schwarz	1994	2
17	Opposing cytokine production by normal Langerhans cells (IL-12) and UV-induced macrophages (IL-10) Journal of Investigative Dermatology ·Kevin D. Cooper, Kyeongah Kang, Marek Kubin, Giorgio Trinchieri, Alain H. Rook	1994	1
18	Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. The Journal of Experimental Medicine ·Marek Kubin, Malek Kamoun, Giorgio Trinchieri	1994	305
19	Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. The Journal of Experimental Medicine ·Annalisa D’Andrea, Manthrasalam Rengaraju, Nicholas M. Valiante, Jihed Chehimi, Marek Kubin, میر جلال کمری, Susan Chan, Michiko Kobayashi, Deborah Young, Elliot Nickbarg Hit paper breakdown →	1992	1025
20	Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation PubMed ·Giorgio Trinchieri, Maria Wysocka, Annalisa D’Andrea, Manthrasalam Rengaraju, Miguel Aste-Amézaga, Marek Kubin, Nicholas M. Valiante, Jihed Chehimi	1992	142

About Marek Kubin

Marek Kubin is a scholar working on Immunology, Dermatology, Cancer Research, Hematology and Epidemiology, having authored 53 papers that have together received 11.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (24 papers), T-cell and B-cell Immunology (16 papers), Immune Response and Inflammation (11 papers), Immunotherapy and Immune Responses (8 papers), Cell death mechanisms and regulation (7 papers), NF-κB Signaling Pathways (7 papers), interferon and immune responses (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Immunology (8.0k citations), Cancer Research (1.3k citations), Oncology (2.3k citations), Dermatology (609 citations) and Molecular Biology (3.8k citations). Marek Kubin has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Giorgio Trinchieri, Annalisa D’Andrea, David Cosman, Thomas S. Griffith, Wilson Chin, Nicholas M. Valiante, David H. Lynch, Miguel Aste-Amézaga, Neil A. Fanger and Xiaojing Ma. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, Journal of Investigative Dermatology, Blood and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact